Abb Ltd.-RegABLZF

13F holders, Q2 2025 (June 30)
2holders −1
0new positions
1sold out
$59.66avg. 13F price*

At the end of Q2 2025, 2 institutions reported holding Abb Ltd.-Reg (ABLZF) in their 13F filings, down 1 from Q1 2025. 0 opened new positions and 1 sold out. The largest holders were Partners Capital Investment Group, LLP ($4.4M) and Generali Investments CEE, investicni spolecnost, a.s. ($901K).

Company
Abb Ltd.-Reg
CUSIP
H0010V101
Latest filing quarter
Q2 2026

History

Number of 13F holders

0123 Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q1 2025: 3Q1 2025Q2 2025: 2Q2 2025Q3 2025: 2Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions0$0
Exits1$10K

All 13F filers, Q1 2025 → Q2 2025: 9,614 shares sold, net −9,614 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

Partners Capital Investment Group, LLP 0.18% Reduce -8.2% 74,204 $4.4M
Generali Investments CEE, investicni spolecnost, a.s. 0.07% Reduce -15.6% 15,103 $901K

"% of holder's portfolio" is ABLZF's weight in each manager's 13F, not the share of Abb Ltd.-Reg the manager owns.